ESR vs CRP: Inflammatory Markers in Primary Care Explained

Blood is a specialized connective tissue with 6-7 liters in adults (7-8% body weight). Plasma is 91-92% water and 7-8% organic substances including glucose, amino acids, vitamins, and hormones. Major plasma proteins: albumin (50%, maintains oncotic pressure, transports substances), globulins (immunoglobulins for immunity, transport proteins), and fibrinogen (largest, essential for clotting). Erythrocytes are anucleated cells (7.8 micrometer diameter, 2.6 micrometer thickness) with biconcave discs enabling capillary passage. They circulate 120 days, containing hemoglobin (four polypeptide chains with iron-containing heme groups binding oxygen). Major types: HbA (96% adult), HbA2 (1.5-3%), HbF (fetal predominant).

Plasma proteins include albumin (3.4-5.5 g/dL, maintains 75-80% osmotic pressure, transports fatty acids/bilirubin/drugs), globulins (2.2-3.5 g/dL, include alpha-1/alpha-2/beta/gamma subtypes with specific functions like immune defense and transport), and fibrinogen (200-450 mg/dL, essential for clotting). Erythropoiesis (RBC production) begins in the third week of intrauterine life and continues throughout life. Stages: proerythroblast (high N:C ratio, condensed chromatin, basophilic cytoplasm), early normoblast (round nucleus, mature chromatin, red cytoplasm), intermediate normoblast, late normoblast (pyknotic nucleus), reticulocyte (blue tinge from ribonucleoproteins), and mature erythrocyte (biconcave disc, central pallor, no nucleus). Hemoglobin synthesis causes color change from blue to red.

Plasma proteins include albumin (most important, determines oncotic pressure), globulins (immune and non-immune types), and fibrinogen (largest protein, converted to fibrin for clotting). Globulins include immunoglobulins (IgG, IgA, IgM, IgE, IgD) and transport proteins (transferrin, apoprotein). Blood formed elements include erythrocytes (anucleated, 120-day lifespan), leukocytes (granulocytes and agranulocytes), and platelets (anucleated fragments from megakaryocytes). Erythrocytes have biconcave disc shape (7-8 μm diameter, 0.8 μm central thickness) maximizing surface area for gas exchange. Membrane proteins (glycophorin C, band 3, spectrin) enable deformability for capillary passage. Erythrocytes contain blood group antigens (A, B, AB, O) and Rh factor, critical for safe transfusions. Hemoglobin (12-16 g/dL) is a quaternary protein with four chains (alpha, beta, gamma, delta) and heme groups containing iron for oxygen binding.

Plasma proteins include albumin (4.5 g/dL, highest concentration), globulins (2.5-2.7 g/dL, including alpha, beta, and gamma fractions), and fibrinogen (200-400 mg/dL). Plasma proteins are essential for blood clotting - fibrinogen converts to fibrin forming a mesh that traps blood cells. They determine blood viscosity - large molecules like fibrinogen and globulins increase thickness. Erythrocyte Sedimentation Rate (ESR) measures red blood cell settling speed; fibrinogen and globulins increase ESR by neutralizing negative charges on red blood cells, causing clumping. Elevated ESR indicates inflammation or infection.

Plasma proteins include albumin (maintains osmotic pressure, prevents edema), globulins (immune function and transport), and fibrinogen (coagulation). Erythrocytes are anucleated biconcave discs (7.8 μm diameter) containing hemoglobin for oxygen transport. They lack organelles and live 120 days before macrophage destruction.

C-reactive protein (CRP) is a primary acute phase protein secreted by the liver during inflammatory responses to infections or tissue damage. It modulates inflammation through dual mechanisms—activating complement and phagocytes while reducing neutrophil activation. CRP production is primarily driven by interleukin-6 (IL-6), with IL-1β and TNF-alpha acting synergistically to amplify secretion. This cytokine-mediated regulation creates a feedback loop where inflammatory signals trigger hepatic CRP release, which in turn helps resolve inflammatory processes.

CRP performs multiple physiological functions beyond serving as an inflammatory marker: It enhances phagocytosis by binding to damaged cells and promoting their clearance by macrophages. It activates the complement system to recruit immune cells. It regulates immune cell migration and function. These functions make CRP essential for effective immune response and tissue repair, explaining why complete suppression of CRP production would impair healing capacity.

C-Reactive Protein (CRP) is an acute phase reactant synthesized in the liver in response to interleukin-6 during inflammation, infection, necrosis, or trauma; it has a normal plasma level of 0.8-3 mg/L, serves as a prognostic marker for cardiovascular disease risk (with levels >3 mg/L indicating high risk), and is more clinically useful than ESR for monitoring disease activity and treatment response due to its rapid rise and fall (half-life of 7 hours versus 7 days for ESR), though it lacks diagnostic specificity as it can be elevated in numerous conditions including infections, malignancies, autoimmune diseases, and allergic reactions.

C-reactive protein (CRP) is a blood protein that serves as a critical biomarker for detecting infections and inflammation. Normally present in trace amounts, CRP concentrations surge dramatically during infection, signaling immune cells to mount a defense. Produced primarily by liver hepatocytes, CRP exists as a pentameric protein structure. The elevation mechanism involves macrophages secreting cytokines like IL-6 and IL-1β, which signal the liver to increase CRP production. This represents a rapid cell-mediated immune response preceding the slower humoral antibody response, making CRP an early indicator of systemic infection.

C-Reactive Protein (CRP) is produced by the liver and serves as an acute-phase protein. During acute infections like flu or pneumonia, immune cells release signaling molecules called interleukins that stimulate CRP production. CRP then helps the immune system fight pathogens and clear damaged tissues, eventually leading to recovery.

This comprehensive section establishes the foundational framework for evaluating diagnostic and screening tests. It covers four key terminology pairs: True Positive/False Negative and True Negative/False Positive. Students learn sensitivity = TP/D+ and specificity = TN/D-, along with PPV = TP/(TP+FP) and NPV = TN/(TN+FN). The section distinguishes between validity (accuracy within specified range, measured by sensitivity and specificity) and reliability/precision (consistency of repeated measurements). Diagnostic accuracy is defined as positive predictive value. Students learn that high false positive rate indicates low specificity, and PPV is most affected by prevalence, sensitivity, and specificity. The section emphasizes interpreting MCQ statements without immediately looking at options, building a conceptual framework before applying formulas.

Diagnostic tests have four key concepts: (1) Sensitivity - detects sick individuals (enfermos), (2) Specificity - detects healthy individuals (sanos), (3) Positive Predictive Value - detects positive results (positivos), (4) Negative Predictive Value - detects negative results (negativos). A useful mnemonic is that sensitivity relates to sick people because we are naturally more sensitive to illness, while specificity relates to healthy people. Questions can be asked in two formats: straightforward (e.g., 'capacity to detect positives' = Positive Predictive Value) or complex (mixing multiple key words). For complex questions, always focus on the FIRST key word in the phrase to determine the correct answer.

Diagnostic tests are the second most frequently tested topic in preventive medicine for medical board exams, accounting for approximately 10% of questions. The foundation involves understanding the contingency table 2x2, which organizes results into four subgroups: true positive, false negative, false positive, and true negative. Five key measures are calculated: sensitivity (true positive/total diseased), specificity (true negative/total healthy), accuracy (true positive + true negative/total population), positive predictive value (true positive/total positive results), and negative predictive value (true negative/total negative results). A critical distinction is that sensitivity is calculated when you know the patient is diseased but not the test result, while PPV is calculated when you know the test result is positive but not the disease status. Predictive values are influenced by three factors: sensitivity, specificity, and prevalence. Increasing sensitivity increases NPV and decreases PPV. Increasing specificity increases PPV and decreases NPV. Prevalence has a direct relationship with PPV and an inverse relationship with NPV. Primary care settings are characterized by low prevalence, while specialized care settings have high prevalence. When moving a test from low to high prevalence, PPV increases and NPV decreases. Sensitivity and specificity remain unchanged regardless of prevalence changes.

Sensitivity is the proportion of true positives among all actual diseased individuals, calculated as true positives divided by (true positives + false negatives). For example, with 85 true positives and 15 false negatives, sensitivity is 85/100 = 0.85 or 85%. Specificity is the proportion of true negatives among all actual healthy individuals, calculated as true negatives divided by (true negatives + false positives). For example, with 95 true negatives and 5 false positives, specificity is 95/100 = 0.95 or 95%. Positive predictive value (PPV) is the probability that a positive test result indicates actual disease, calculated as true positives divided by (true positives + false positives). Negative predictive value (NPV) is the probability that a negative test result indicates no disease, calculated as true negatives divided by (true negatives + false negatives).

Diagnostic test characteristics—sensitivity (probability of positive test given disease), specificity (probability of negative test given no disease), positive predictive value (PPV, probability of disease given positive test), and negative predictive value (NPV, probability of no disease given negative test)—are calculated using a 2x2 contingency table; while sensitivity and specificity remain constant regardless of disease prevalence, PPV and NPV change with prevalence (PPV increases and NPV decreases as prevalence rises), and high specificity tests are used to confirm disease while high sensitivity tests are used to rule out disease.